Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/11/22
End: 10/31/25
Due: 10/31/26
Phase: N/A
Priority: Normal
Start: 01/17/25
End: 12/31/27
Due: 12/31/28
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors | NCT05270213 | Riboscience, LLC. | user2@example.com | None | 2022-07-11 | 2025-10-31 | 2026-10-31 | - | - | 2025-07-14 |
| Evaluation of RBS2418 in Patients with Advanced, Metastatic, and Progressive Colorectal Cancer | NCT06824064 | Riboscience, LLC. | user2@example.com | None | 2025-01-17 | 2027-12-31 | 2028-12-31 | - | - | 2025-07-14 |
| Expanded Access RBS2418 Treatment | NCT05683470 | Riboscience, LLC. | user2@example.com | None | - | - | - | - | - | 2025-07-14 |